Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Atorvastatin Loading in STEMI PCI
NCT04974814Unknown
- Sponsor
- Beni Suef University
- Start
- May 2021
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of rosuvastatin and atorvastatin in ST-segment elevation myocardial infarction (STEMI) (3 arms), sponsored by Beni Suef University. Primary endpoints: Corrected TIMI Frame Count at 3 months and ST-segment resolution at 3 months. Status: unknown.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04974814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04974814.